Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
John C Reed sold 19,137 shares of JNJ on 17 July at $163.55 per share, worth a total of $3.1M. They now own 10,658 JNJ shares, or a 64% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!